| Teva says higher dose of MS drug no more efficient |
|
|
|
| Monday, 07 July 2008 | |
|
(Reuters) - Teva Pharmaceutical Industries Ltd said data from a late-stage trial showed an increased dose of its multiple sclerosis drug, glatiramer acetate (GA), was not more efficient than an approved lower-dose version of the drug.
|
| < Prev | Next > |
|---|